Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

Launched by INSTITUTO NACIONAL DE CANCEROLOGIA DE MEXICO · Nov 28, 2016

Keywords

ClinConnect Summary

This clinical trial is studying how pulmonary rehabilitation (PR), a type of exercise and support program, can help patients with advanced non-small cell lung cancer (NSCLC). The goal is to see if PR can improve patients' quality of life, help them maintain muscle mass, and reduce fatigue while they are receiving treatments like chemotherapy. This is important because many patients with advanced lung cancer experience muscle loss, which can lead to more complications and a worse overall health status.

To participate in this trial, individuals need to have a confirmed diagnosis of advanced NSCLC and a good performance level (meaning they can carry out daily activities with little trouble). They should also expect to live longer than 12 weeks and be eligible for treatment with chemotherapy or specific targeted therapies. However, those with uncontrolled pain or other serious health issues, as well as those who are very active in physical exercise, may not be eligible. Participants will attend therapy sessions in Mexico City, where they can expect support and guidance to help improve their physical well-being during treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of advanced non-small-cell lung cancer
• • Good performance status (ECOG 0-1)
• • Life expectancy \>12 weeks
• • Eligible to receive treatment with chemotherapy or tyrosinkinase inhibitors
• • Recent electrocardiogram without evidence of arrythmia
• Exclusion Criteria:
• • Symptomatic brain metastasis
• • Uncontrolled pain (Visual Analog Scale \>5)
• • Uncontrolled hypertension (\>140/100mmHg)
• • Practice of regular moderate to intense physical activity at least 3 day/week
• • Not residents of Mexico City or unable to attend to therapy sessions